Skip to content
MomMetabolicEVIDENCE-FIRST METABOLIC HEALTH
Menu
Grade C

NavioMD review

Written by Elena Voss, Metabolic Health Editor

Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.

Semaglutide: Current semaglutide cash price not publicly itemized; tirzepatide: Compounded from $189/mo. Zepbound is advertised from $445 monthly, but the current public catalog does not establish a semaglutide cash price.

$189/mo
Consult Medication Shipping
See plans at NavioMD
  • Confirm HSA / FSA coverage
  • Public information reviewed
  • Confirm your total cost
Compare alternatives ↓

NavioMD at a glance

Semaglutide
Current semaglutide cash price not publicly itemized
Tirzepatide
Compounded from $189/mo
Coverage
48 states (not AL or MS)
Brand-name
Yes

How we scored NavioMD

Every factor comes from NavioMD's own published pricing, disclosures and oversight, and the six combine into the 50/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.

Postpartum & breastfeeding guidance35/100 · Weak

No postpartum or breastfeeding framing — a generic weight program.

PCOS & hormonal fit45/100 · Weak

Thin on the hormonal picture that drives many mothers' weight.

Clinical oversight & labs58/100 · Weak

Oversight and lab support fall short of the best on our list — the review below says exactly where.

True monthly cost58/100 · Weak

Cost is unpredictable or sits at the premium end.

Ongoing support55/100 · Weak

Support is thin once the prescription ships.

Cancellation fairness52/100 · Weak

Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.

How we checked this review

Semaglutide: Current semaglutide cash price not publicly itemized; tirzepatide: Compounded from $189/mo. Zepbound is advertised from $445 monthly, but the current public catalog does not establish a semaglutide cash price.

Before you sign up

What NavioMD's public site and signup page show before you hand over any details.

Worth knowing

  • Homepage leads with 'Meet with a provider instantly' and a tiered pricing grid for both compounded tirzepatide and brand-name Ozempic/Zepbound/Mounjaro
  • Also offers a women's-hormone menu (progesterone capsules, Biest) alongside weight loss, on the same site
  • FAQ names its exclusive pharmacy partner directly — The Pharmacy Hub — for both compounded and branded medication fulfillment
  • States operation in 48 states, explicitly excluding Alabama and Mississippi, with automatic eligibility verification during intake
  • No compounded semaglutide option was found on this site — readers wanting semaglutide specifically would need to go the brand-name Ozempic route at a meaningfully higher price ($345/mo vs $189/mo for compounded tirzepatide)
  • Same-day provider access is a genuine claim — 'available instantly from the hours of 9am-10pm EST'
  • Names its pharmacy partner directly (The Pharmacy Hub), a real transparency plus
  • Offers a parallel women's-hormone menu (progesterone, Biest), though nothing pregnancy- or breastfeeding-specific was found

Pricing

MedicationPricePlan
Compounded tirzepatide$189Advertised starting planCompounded starting rate, not confirmed all-dose or renewal price.
Brand tirzepatide$445Zepbound starting optionPublic as-low-as brand cash figure; dose and plan qualifications require confirmation.

Swipe the table to see plan details →

Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what NavioMD's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.

What we like

  • Same-day, instant provider access, per the site — one of the faster claimed timelines we've seen
  • Names its exclusive pharmacy partner (The Pharmacy Hub) directly
  • Offers brand-name Ozempic®, Zepbound®, and Mounjaro® alongside compounded tirzepatide
  • Parallel women's-hormone menu (progesterone, Biest) on the same platform
  • Semaglutide: Current semaglutide cash price not publicly itemized; tirzepatide: Compounded from $189/mo.

The caveats

  • No mention anywhere of pregnancy or breastfeeding-specific guidance, despite the parallel women's-hormone menu
  • Not available in Alabama or Mississippi
  • No published statement on whether a video visit is required
  • Zepbound is advertised from $445 monthly, but the current public catalog does not establish a semaglutide cash price.

The current public floor is for compounded tirzepatide

NavioMD advertises compounded tirzepatide from $189 a month. That is a starting figure, not a confirmed all-dose maintenance price. Ask for the amount at the prescribed dose, the quantity supplied and the renewal charge before comparing it with a service that explicitly publishes one flat price across every dose.

The current public catalog also advertises Zepbound from $445 a month. Keep that brand-drug quote separate from the compounded floor, including any dose or plan qualifications. The two figures describe different products, and the lower compounded amount should not be used as evidence of what a patient will pay for the named brand medication.

Semaglutide pricing should remain an open question

Earlier Navio material listed brand Ozempic and Mounjaro alongside Zepbound and compounded tirzepatide. The current catalog does not establish a semaglutide cash price, so an older Ozempic amount should not be carried forward as the present offer. That gap also does not prove that semaglutide is unavailable through the clinical service.

Someone specifically seeking semaglutide should ask which product, if any, is currently offered and obtain its actual pharmacy and care charges. The absence of a current itemized price is a reason to resolve the question, not a reason to substitute the tirzepatide floor or assume that all brand options use the same payment arrangement.

Fast access is a seller claim to define

Navio advertises instant or same-day provider access, with published hours described as 9 a.m. to 10 p.m. Eastern in the earlier service material. That may appeal to someone who wants a prompt initial review. It does not establish immediate prescribing, pharmacy dispatch or delivery, since those are separate stages after access to a professional.

Ask what kind of contact is available, whether a live video appointment is required or offered and how the service handles questions after the initial prescription. Its public information does not settle a universal video requirement. Speed is useful only when paired with an understandable route to continuing clinical advice rather than a one-time access promise.

The pharmacy and state limits are identifiable

Navio names The Pharmacy Hub as its pharmacy partner. That disclosure gives the reader a concrete fulfillment organization to ask about, rather than leaving the dispensing arrangement entirely generic. Confirm that the chosen formulation is filled through that partner and how questions about the product or shipment reach the appropriate pharmacy contact.

Its published service footprint is 48 states, excluding Alabama and Mississippi. Confirm access to the selected product within the relevant state rather than treating the footprint as an individual approval. The named pharmacy and explicit exclusions are useful transparency features, but neither answers whether a particular prescription will be appropriate for the patient.

The hormone menu is not a maternal-care pathway

Navio’s broader platform includes women’s-hormone products such as progesterone and Biest. That may matter to someone wanting several concerns discussed on one platform, but it does not establish dedicated pregnancy, breastfeeding or postpartum guidance. Ask who evaluates the specific concern and whether coordination with an existing clinician is part of the service.

NavioMD is most relevant to a reader interested in compounded tirzepatide or a separately quoted brand route who values rapid initial access and an identifiable pharmacy partner. Its $189 starting figure is useful for shortlisting, while the unknown maintenance amount and unitemized semaglutide cost limit a final comparison. Obtain a prescription-specific quote, follow-up arrangement and cancellation terms before deciding on the basis of the starting price.

The bottom line for mothers

Best for: Someone comfortable with the stated plan commitment who confirms the full prescribed treatment cost before paying.

Alternatives to NavioMD

These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.

  • CoreAge RxFeatured partner

    CoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.

    Visit CoreAge Rx
  • RxSpan MD is a genuinely well-disclosed service wrapped in marketing that undercuts it. The disclosure: four compounding pharmacies named with phone numbers, two lead physicians named with NPI numbers that verify as active MDs, flat pricing posted before any intake, both compounded and real FDA-approved brand GLP-1s on one platform, and oral capsules for anyone who won't inject. Compounded semaglutide is $249 a month and tirzepatide $329, with brand Zepbound at $1,069, Ozempic at $1,299 and Wegovy at $1,349. The marketing is the problem. Its testimonials still name a different company — one patient describes what she 'expected from CareGLP' — and the doctors quoted in them are not the clinicians the same page names as its medical team. The homepage is built around a board-certified plastic surgeon who founded the practice but is licensed in California only and isn't the prescriber. Its compounded prices also sit above the typical price we track, and the oral capsules cost the same or more than the injections.

    Visit RxSpan MD
  • FDA warning letter #728279 (June 2026), which names Eden's website — read that first. Then read the price twice: the advertised $99 is medication alone, with a required $99-a-month membership on top.

    Visit Eden

Providers like NavioMD

Keep comparing NavioMD

NavioMD, answered

How much does NavioMD cost?
At last review, NavioMD's lowest ongoing compounded rate was about $189/mo — Current semaglutide cash price not publicly itemized for semaglutide, Compounded from $189/mo for tirzepatide. This market re-prices often, so check the current all-in figure at the source before committing.
Is NavioMD safe to use while breastfeeding?
None of these drugs is established as safe in pregnancy, so stopping before you try to conceive is the usual plan. For breastfeeding, the Zepbound and Mounjaro labels report little or no data on the drug in breast milk and ask you and your clinician to weigh the benefits of breastfeeding against your need for the medicine. Compounded versions carry no label of their own; ask the prescriber directly how they handle nursing patients. NavioMD is not an exception to any of that — settle the timing with your own clinician.
Does NavioMD offer both semaglutide and tirzepatide?
Yes — NavioMD offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
How does NavioMD score for mothers?
NavioMD scores 50/100 on our Metabolic-Fit Score, a weighted read of six things mothers actually have to care about. CoreAge Rx, a featured partner, is worth a side-by-side look.

Pricing, states and verification reflect NavioMD's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.

← Back to all providers